Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,009 across all filing types
Latest filing 2017-01-03 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
股票交易异常波动核查结果暨复牌的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the abnormal stock price fluctuations and the subsequent suspension and resumption of trading for the company's shares. It includes details about the investigation into the price movements, confirmation of no undisclosed material information, and the official date for resumption of trading. There are no financial statements, detailed financial data, or comprehensive reports included. The document is short (1546 characters) and serves as a regulatory announcement about stock trading status and investigation results. This fits the category of a Regulatory Filing (RNS) rather than a full report or other specific filing types.
2017-01-03 Chinese
关于重大资产重组申请材料获得中国证监会行政许可申请受理的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the acceptance of an administrative license application by the China Securities Regulatory Commission (CSRC) for a major asset restructuring by the company. It mentions the approval by the shareholders' meeting and the pending regulatory approval. The document is short (528 characters) and serves as a notification of regulatory progress rather than a full report or detailed financial disclosure. It does not contain financial statements or detailed analysis, nor is it a certification or voting result. Therefore, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2017-01-03 Chinese
股票交易异常波动停牌核查的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the suspension of stock trading due to abnormal price fluctuations. It references specific dates and regulatory rules from the Shenzhen Stock Exchange. The content focuses on the company's stock trading halt and the investigation into the abnormal price movements. There is no financial data, no report attached or referenced as being published, and no mention of management changes, dividends, or other report types. This fits the category of a Regulatory Filing (RNS) as it is a compliance announcement related to stock trading and regulatory rules, not a financial report or other specific filing type.
2016-12-28 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Chengdu Tianxing Instrument Co., Ltd. It discusses unusual stock price movements over two trading days, the company's investigation and confirmation that no undisclosed material information exists, and a risk warning to investors. The document does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement related to stock price behavior and compliance with disclosure rules, typical of a Regulatory Filing (RNS). The document length is short (1085 characters), and it is not a report or presentation but an official disclosure notice.
2016-12-25 Chinese
关于控股股东进行股票质押的公告
Capital/Financing Update Classification · 100% confidence The document is a public announcement regarding the pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the pledge start and end dates, the pledgee, and the purpose of the pledge. There is no financial report, earnings data, or management discussion. The document is short (1043 characters) and is clearly an announcement about a capital-related event (share pledge). This fits the category of Capital/Financing Update (CAP).
2016-12-25 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Chengdu Tianxing Instrument Co., Ltd. It discusses the unusual price movement of the company's stock over two trading days, the company's investigation and confirmation that no undisclosed material information exists, and a risk warning to investors. There is no financial data, no report attached or referenced as being published, and no mention of annual or quarterly results, management changes, or other report types. This type of announcement is a regulatory disclosure about stock price behavior and company confirmation, fitting best under Regulatory Filings (RNS). The document length is short (1084 characters), and it is not a report publication announcement or a financial report itself.
2016-12-20 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.